Skip to main content

Month: September 2024

Verizon donates $25,000 to support wildfire relief efforts in Southern California

Funding supports communities hardest hit by the Line Fire, Bridge Fire and Airport Fire IRVINE, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) — With three wildfires still ablaze in San Bernardino County, Orange County, Riverside County and Los Angeles County, California, Verizon is bolstering its support to the affected communities by way of a $25,000 donation to the American Red Cross Los Angeles Region. This donation aims to aid those displaced by the fires. “These wildfires have devastated families and communities, and our hearts are with everyone affected,” said Steven Keller, Pacific Market President at Verizon. “Verizon is committed to supporting communities in times of crisis. We hope our donation to the American Red Cross will provide essential aid and offer hope during this challenging time.” Verizon is committed to keeping...

Continue reading

Kairos Pharma Prices $6.2 Million Initial Public Offering

Company anticipates commencement of trading on the NYSE American effective September 16, 2024 under the symbol “KAPA” LOS ANGELES, Sept. 16, 2024 (GLOBE NEWSWIRE) — Kairos Pharma, Ltd. (“Kairos Pharma” or the “Company”), a clinical stage biopharmaceutical company developing cancer therapeutics designed to reverse cancer drug resistance and immune suppression, announces the pricing of its initial public offering of 1,550,000 shares of common stock at a public offering price of $4.00 per share. In addition, the Company has granted to the underwriters a 45-day option to purchase up to an additional 232,500 shares of common stock at the public offering price of $4.00 per share, less underwriting discounts and commissions, to cover over-allotments, if any. The Company’s common stock has been approved for listing on the NYSE American...

Continue reading

Allied Announces September 2024 Distribution

TORONTO, Sept. 16, 2024 (GLOBE NEWSWIRE) — Allied Properties REIT (“Allied”) (TSX:AP.UN) announced today that the Trustees of Allied have declared a distribution of $0.15 per unit for the month of September 2024, representing $1.80 per unit on an annualized basis. The distribution will be payable on October 15, 2024, to unitholders of record as at September 30, 2024. About Allied Allied is a leading owner-operator of distinctive urban workspace in Canada’s major cities. Allied’s mission is to provide knowledge-based organizations with workspace that is sustainable and conducive to human wellness, creativity, connectivity and diversity. Allied’s vision is to make a continuous contribution to cities and culture that elevates and inspires the humanity in all people. FOR FURTHER INFORMATION, PLEASE CONTACT: Cecilia C. Williams, President...

Continue reading

Impact BioMedical Inc. Announces Pricing of Initial Public Offering

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) — Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness today announced the pricing of its initial public offering of 1,500,000 shares of its common stock at a public offering price of $3.00 per share. The shares are expected to begin trading on the NYSE American Market on September 16, 2024, under the ticker symbol “IBO.” The offering is expected to close on September 17, 2024, subject to the satisfaction of customary closing conditions. In addition, Impact has granted the underwriters a 45-day option to purchase an additional 225,000 shares of its common stock at the public offering price, less underwriting discounts, and commissions. All of the shares of common stock are being offered by Impact Biomedical. Revere...

Continue reading

Psyence Group’s NASDAQ-Listed Associate, Psyence Biomedical, Announces Initiation of First Trial Site in Australia for its Phase IIb Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) — Psyence Group Inc (“Psyence Group“) (CSE: PSYG), a life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, is pleased to announce that its NASDAQ-listed associate, Psyence Biomedical Ltd (NASDAQ: PBM) (“PBM” or “Psyence Biomed“), has successfully completed the first site initiation visit at the first Australian clinical trial site for PBM’s Phase IIb study of nature derived (non-synthetic) psilocybin as a potential treatment for Adjustment Disorder in the Palliative Care context. According to a news release issued by Psyence Biomed on Monday, September 9, 2024, it has entered into partnerships with Fluence, a global leader in professional education and training for psychedelic therapy research,...

Continue reading

IREN to increase AI Cloud Services to 10% of earnings

Purchase of additional 1,080 NVIDIA H200 GPUs SYDNEY, Sept. 16, 2024 (GLOBE NEWSWIRE) — Iris Energy Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN”) today announced the purchase of 1,080 latest-generation NVIDIA H200 GPUs to support its growing AI Cloud Services business. “We’re seeing strong levels of demand for new-generation GPUs. Ongoing discussions with NVIDIA and participation in their Cloud Partner Program gives us added confidence in deploying this new capacity,” said Daniel Roberts, Co-Founder and Co-CEO of IREN. “This purchase is estimated to increase the AI Cloud Services proportion of IREN earnings to ~10% by year-end, a proportion we expect to continue growing through 2025.” 1 Expansion of AI Cloud Services IREN is purchasing 1,080 of the latest-generation NVIDIA H200 GPUs for $43.9m2, with delivery...

Continue reading

The world’s first ship-to-ship ammonia transfer at anchorage: “A major milestone to decarbonize shipping fuel”

Navigator Global and the Green PioneerNavigator Global and the Green Pioneer at dusk at the outer anchorage of Port DampierThe Green Pioneer and the Navigator Global with tugboatsThe Green Pioneer and the Navigator Global with ex-AMSA anchor handling tug supply vessel, Coral Knight, and Rio Tinto tugboats at the outer anchorage of Port DampierRepresentatives of the tripartiteFrom left to right – Laurent Jackie Trost, Chief Operations Officer, Yara Pilbara, Prof Lynn Loo, CEO, GCMD, Mike Minogue, Harbour Master, Marine West, Pilbara PortsThe world’s first ship-to-ship transfer of ammonia using vessels at anchorage in a working port environment has been completed. The transfer is a significant step towards realizing ammonia as a shipping fuel and enable bunkering worldwide. Yara contributed with their experience...

Continue reading

Ferrellgas Honors its Drivers During National Truck Driver Appreciation Week

LIBERTY, Mo., Sept. 16, 2024 (GLOBE NEWSWIRE) — Ferrellgas Partners, L.P. (OTC: FGPR), is honoring our Drivers during National Truck Driver Appreciation Week. Without them, we wouldn’t be able to do what we do – deliver easy propane service to millions of families. This year, Ferrellgas’ theme for National Truck Driver Appreciation Week is Miles of Gratitude. Whether our Drivers are hauling propane across the country as part of Ferrell North America (FNA), delivering it to someone’s home or business as part of Ferrellgas operations, or refilling a display of Blue Rhino grilling cylinders at a store, every mile counts. Our propane gets to its final destination safely and efficiently because of them, and we’re proud to have them as a key part of our nationwide supply network. “At the end of the day, we deliver propane. We couldn’t...

Continue reading

Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

MORRISVILLE, N.C., Sept. 16, 2024 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) (Liquidia), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, announced today that the United States District Court for the District of New Jersey (District Court) has found that the interference by United Therapeutics Corporation (United Therapeutics) with the launch of generic Treprostinil Injection caused losses in excess of $137M. Treprostinil Injection is manufactured by Sandoz Inc. (Sandoz) and was launched as the first-to-file, fully-substitutable generic treprostinil for parenteral administration in March 2019. Liquidia PAH, LLC (formerly known as RareGen), a wholly owned subsidiary of Liquidia (Liquidia PAH), partnered with Sandoz in August 2018 on an exclusive basis to market...

Continue reading

Healthy Choice Wellness Corp. Announces Listing on NYSE American, Pricing of Initial Public Offering and Completion of Spin-Off from Healthier Choices Management Corp.

HOLLYWOOD, FL, Sept. 16, 2024 (GLOBE NEWSWIRE) — Healthy Choice Wellness Corp. (“HCWC” or the “Company”) (NYSEAM: HCWC), a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives, announced today the pricing of its initial public offering of 400,000 shares of the Company’s Class A common stock, par value $0.001 per share, at an offering price of $10.00 per share, for gross proceeds of approximately $4.0 million, before deducting underwriting discounts and offering expenses (the “Offering”). In addition, HCWC has granted the underwriters a 45-day option to purchase up to an additional 60,000 shares of Class A common stock to cover over-allotments at the initial public offering price, less the underwriting discount. The Company also announced today that...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.